top of page
Search
  • Writer's picturePharma Nuclear Services

What's new ?


This qualification is the first time a regulatory body has formally supported a machine learning-based method for reducing sample size in Phase II or III trials.










21 views0 comments

Recent Posts

See All
bottom of page